Allergy/Asthma News

Patients with COPD, asthma and cystic fibrosis may soon be able to monitor their diseases by using/breathing through a tool that connects to their smartphone, according to a University of Pittsburgh press release.

Adults and caregivers reported psychological stress caused by food allergy. However, only a fifth of patients reported seeking mental health resources, according to a study published in Allergy.

Patients with primary immunodeficiencies experience an average of 9 to 15 years between the onset of their symptoms to diagnosis of their disorder and treatment that could save their lives, according to the Immune Deficiency Foundation.

BOSTON — Amidst climate change, it is important that pulmonologists/critical care experts consider the impact worsening particulate matter, ozone and allergens have on their patients, according to a presentation at the CHEST Annual Meeting.

PHILADELPHIA — A once-weekly 360 mg dose of cendakimab sustained improvements in symptoms and endoscopic/histologic features of eosinophilic esophagitis at 48 weeks, according to data presented at the ACG Annual Scientific Meeting.

Caregivers of children with food allergy among minoritized racial and ethnic groups were less familiar with oral immunotherapy than caregivers of non-Hispanic white children with food allergy, according to a recent study.

Epinephrine autoinjectors may be associated with short-lived peak plasma levels, unpredictable cardiovascular responses as well as varying epinephrine absorption, according to a review published in Clinical and Experimental Allergy.

The relationship between health care providers and referral sources can present complex legal challenges.

BOSTON — Among caregivers of children with asthma, 54% did not “strongly agree” or “agree” that biologics are safe, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Dermavant Sciences presented full results from its long-term extension trial of Vtama cream 1% for the treatment of atopic dermatitis at the Fall Clinical Dermatology Conference, the company announced in a press release.